Citation

Fujita Y, Takahashi K, Takei M, Niitsu H, Aoki Y, Onodera M, Fujino Y, Inoue Y, Endo S. Yakugaku Zasshi 2008; 128(10): 1507-1512.

Affiliation

Critical Care and Emergency Center, Iwate Medical University Hospital, Japan. yfujita@iwate-med.ac.jp

Copyright

(Copyright © 2008, Pharmaceutical Society of Japan)

DOI

unavailable

PMID

18827472

Abstract

In this study, we measured the urine concentrations of methamphetamine and amphetamine as metabolites of selegiline after ingestion of an overdose of selegiline. A patient who had developed Parkinson disease took selegiline in a suicide attempt. Analysis by gas chromatography-mass spectrometry (GC-MS) with trifluoroacetic acid-derivatization revealed the presence of methamphetamine and amphetamine in the patient's urine at concentrations of 0.62 microg/ml and 0.25 microg/ml, respectively. To determine the stereospecificity of the methamphetamine and amphetamine, a urine sample was analyzed by GC-MS after derivatization with N-(trifluoroacetyl)-l-prolyl chloride. The methamphetamine and amphetamine were levorotatory in form. The ratio of the methamphetamine to amphetamine concentration in the urine was 2.5. This value is consistent with other case reports of ingestion of selegiline, which suggests that the methamphetamine to amphetamine concentration ratio in urine is useful information for indicating use of selegiline.

Language: en